- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0011576

Anshuparth Pharmaceutical Private Limited
About Anshuparth Pharmaceutical Private Limited
Data last updated:
Anshuparth Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85320DL2018PTC330655. Its GSTIN is 09AAQCA6219G1ZF (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹19.9 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Jang Bahadur Yadav and Arvind Kumar Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 229 Ground Floor Jor Bagh, New Delhi, Delhi, India – 110003.
As per the financials filed for FY 2023, the company reported a revenue of ₹11.9 Lakh, a growth of 128% compared to the previous year. For the same year it recorded a net loss of ₹1 Lakh (net margin -8.4%) and EBITDA of -₹6,152 (EBITDA margin -0.5%).
Anshuparth Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0011576).
Company details
Recognitions & Rankings of Anshuparth Pharmaceutical
Contact details
Anshuparth Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address229 Ground Floor Jor Bagh, New Delhi, Delhi, India – 110003
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Anshuparth Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anshuparth Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Anshuparth Pharmaceutical Private Limited, buy the company report.
Financials of Anshuparth Pharmaceutical Private Limited
FY 2025 filings availableAnshuparth Pharmaceutical Private Limited reported revenue of ₹11.9 Lakh (up 128% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 128% in the latest year. EBITDA fell 168% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6,152 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.5% | ||||
| Net Profit Margin | -8.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anshuparth Pharmaceutical Private Limited, buy the company report.
Board of directors of Anshuparth Pharmaceutical Private Limited
Anshuparth Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jang Bahadur Yadav | Director | 26 Dec 2019 | 6 Years 10 Months | Current |
| Arvind Kumar Yadav | Director | 14 Oct 2021 | 5 Years 0 Months | Current |
| Amit Kumar Yadav | Director | 12 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Anshuparth Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goldenbond Ventures Private Limited | ₹11.95 Lakh (FY 2025) | -1.0% | Ghaziabad, Uttar Pradesh, India | |||
| Vedan Industries Private Limited | ₹11.93 Lakh (FY 2025) | -95.0% | Chennai, Tamil Nadu, India | |||
| Ratnamani Pipe and Pipe Fittings Private Limited | ₹11.93 Lakh (FY 2025) | 1433.0% | Mumbai, Maharashtra, India | |||
| Workowhole Private Limited | ₹11.91 Lakh (FY 2025) | 39.0% | Nagpur, Maharashtra, India | |||
| Yash Dealers Private Limited | ₹11.91 Lakh (FY 2025) | -88.0% | Kolkata, West Bengal, India | |||
| Anshuparth Pharmaceutical Private Limitedthis company | ₹11.9 Lakh (FY 2023) | -₹1 Lakh | -8.4% | 128.0% | New Delhi, Delhi, India | |
| Nahata Leasing Private Limited | ₹11.89 Lakh (FY 2025) | -54.0% | Mumbai, Maharashtra, India | |||
| Elvtac Ind Private Limited | ₹11.88 Lakh (FY 2025) | -77.0% | Mumbai, Maharashtra, India | |||
| Suvarnanil Agro Private Limited | ₹11.87 Lakh (FY 2024) | 121.0% | Alamprabhu Road, Maharashtra, India | |||
| Patag Impex & Consultancy Private Limited | ₹11.86 Lakh (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Forgene Lifesciences Private Limited | ₹11.86 Lakh (FY 2025) | 332.0% | Pune, Maharashtra, India |
To see the full peer comparison of Anshuparth Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anshuparth Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anshuparth Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anshuparth Pharmaceutical has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAQCA6219G1ZF | Uttar Pradesh | Active | 16 Feb 2021 |
To see the full GST registrations and return filing status of Anshuparth Pharmaceutical Private Limited, buy the company report.
Recent activity
Anshuparth Pharmaceutical Private Limited has 4 board changes on record since 2018: 3 appointments and 1 cessation. The latest: Arvind Kumar Yadav was appointed as Director on 14 Oct 2021.
Frequently asked questions
Anshuparth Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 March 2018 (8+ years old) and is registered under CIN U85320DL2018PTC330655.
Anshuparth Pharmaceutical has 3 current directors:
- Jang Bahadur Yadav - Director
- Arvind Kumar Yadav - Director
- Amit Kumar Yadav - Director
The latest financial statements of Anshuparth Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Anshuparth Pharmaceutical is 09AAQCA6219G1ZF, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Anshuparth Pharmaceutical is U85320DL2018PTC330655. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anshuparth Pharmaceutical was incorporated on 12 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Anshuparth Pharmaceutical by revenue are Goldenbond Ventures Private Limited, Vedan Industries Private Limited, Ratnamani Pipe and Pipe Fittings Private Limited, Workowhole Private Limited, Yash Dealers Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Arvind Kumar Yadav was appointed as Director on 14 Oct 2021. Sanjit Agnideo Upadhyay ceased to be Director on 27 Jan 2021. Jang Bahadur Yadav was appointed as Director on 26 Dec 2019. Anshuparth Pharmaceutical has 4 board changes on record in total.
Yes, Anshuparth Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0011576).
The registered office of Anshuparth Pharmaceutical is at 229 Ground Floor Jor Bagh, New Delhi, Delhi, India – 110003.
Anshuparth Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.